Table 2. Familiarity with and attitudes regarding PrEPa.
| Variable | N = 86b | |
| Familiarity with PrEP | ||
| Not at all familiar | 14 (16.5) | |
| Somewhat familiar | 32 (37.7) | |
| Very familiar | 39 (45.9) | |
| Have been asked about PrEP in the last year | 28 (32.6) | |
| Number of occasions | 2 (2,10) | |
| Category of patient inquiring about PrEP | ||
| MSM | 22 (71.0) | |
| Serodiscordant couple | 14 (60.9) | |
| Commercial sex worker | 1 (8.3) | |
| Intravenous drug user | 1 (8.3) | |
| Have ever prescribed PrEP | 11 (12.9) | |
| Number of occasions in past year | 2 (1,4) | |
| Category of patients to whom PrEP was prescribed | ||
| MSM | 7 (38.9) | |
| Serodiscordant couple | 5 (31.3) | |
| Commercial sex worker | 1 (8.3) | |
| Other (“Pregnancy attempt”) | 1 (8.3) | |
| Enthusiasm if ever discussed PrEP with a patient | ||
| Unenthusiastic | 3 (3.5) | |
| Neutral | 25 (29.1) | |
| Enthusiastic | 8 (9.3) | |
| Not applicable | 50 (58.1) | |
| Proportion willing to prescribe PrEPc | ||
| Willing | 39 (45.5) | |
| Unwilling | 4 (4.7) | |
| Unsure | 43 (50) | |
| Minimum acceptable level of protection provided by PrEP (%) for it to be recommended to high-risk individuals | 66 (40,80) | |
| Belief that Health Canada should approve PrEP for use in Canadad | ||
| Yes | 41 (49.4) | |
| No | 11 (13.3) | |
| Maybe | 31 (37.4) | |
a
Values shown are number (percentage) or median (IQR).
b
Responses may not sum to 86 due to missing values.
c
Proportion of respondents willing to prescribe PrEP based on current knowledge for high-risk patients who have a mechanism to cover medication costs.
d
Response to question “According to one study among men who have sex with men (MSM), oral PrEP provided 44% protection against HIV infection overall and 73% protection in participants who used PrEP consistently (i.e. took the medication on a regular schedule and did not miss doses). Other studies show that PrEP provides a similar level of protection among heterosexual men and women. Considering this level of protection, do you believe Health Canada should approve PrEP for use in Canada?”